Biopharmaceutical Consulting & Services
Total Trials
1
As Lead Sponsor
0
As Collaborator
Total Enrollment
47
NCT05174806
Multi-center Study to Assess Safety, Tolerability and Efficacy of Topical Pravibismane in Moderate DFI Patients
Phase: Phase 2
Role: Collaborator
Start: Jun 13, 2022
Completion: Jan 19, 2024
Loading map...